Datacubed Health, a Sterling Partners Portfolio Company, Soars with 150% Year-Over-Year Growth

InformedNow04 mins

Datacubed Health, a Sterling Partners Portfolio Company, Achieves Substantial Year-Over-Year Growth Brooklyn, New York, Dec. 20, 2022 (GLOBE NEWSWIRE) — Datacubed Health (“Datacubed”), a digital health technology company that supports hybrid and decentralized clinical trials, and Sterling Partners (“Sterling”), a prominent investment management firm, announced December 20, 2022, substantial year-over-year growth. Datacubed Health, a leading…

Read More

Nektar Therapeutics Advances in Atopic Dermatitis Treatment: Rezpegaldesleukin Granted Fast-Track Designation

marketsgonewild06 mins

Nektar Therapeutics’ Rezpegaldesleukin Receives Fast Track Designation from FDA for Atopic Dermatitis On February 10, 2025, Nektar Therapeutics (Nasdaq: NKTR) announced a significant milestone in the development of their investigational biologic therapy, rezpegaldesleukin. The U.S. Food and Drug Administration (FDA) granted Fast Track designation for this potential treatment for adult and pediatric patients 12 years…

Read More

Lord Mayor Lukwago Calls Out Chinese Contractors for Skipping KCCA Suppliers Conference: A Disappointing Move for Kampala’s Development

marketsgonewild04 mins

Lord Mayor Lukwago criticizes Chinese Contractors Over Dodging KCCA Suppliers’ Conference Kampala City Lord Mayor, Erias Lukwago, did not mince his words when he criticized Chinese Road contractors for failing to attend the KCCA Suppliers’ conference. The conference, which was held at Imperial Royale Hotel, was organized by the Kampala Capital City Authority (KCCA) to…

Read More

“LabCorp’s Q4 Earnings Report: Strong Revenues, But Margins Take a Hit and Stock Falls”

financenews05 mins

LH delivers better-than-expected revenues and earnings in the fourth quarter of 2024 Breaking News: LH Surpasses Q4 Revenue Projections In a surprising turn of events, LH has announced that they have exceeded their revenue and earnings projections for the fourth quarter of 2024. This news comes as a welcome surprise to investors and industry analysts…

Read More

NewAmsterdam Pharma Dishes Out Inducement Grants Like Candy (But With Nasdaq Approval)

marketinsider05 mins

Welcome to the NewAmsterdam Pharma Company N.V. Blog! Breaking News: NewAmsterdam Grants Inducement Share Options Hey there, all you fantastic folks out there in the world of pharmaceuticals and biopharmaceuticals! Today, we’ve got some exciting news from the headquarters of NewAmsterdam Pharma Company N.V. in Naarden, the Netherlands and Miami! In a recent press release,…

Read More

iMac Holdings Inc. Successfully Completes Third Cohort of Phase 1 Clinical Study for Parkinson’s Disease Treatment Using Umbilical Cord-Derived Mesenchymal Stem Cells

marketsgonewild05 mins

IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Allogenic Mesenchymal Stem Cells for Parkinson’s Disease BRENTWOOD, Tenn., Sept. 09, 2022 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or “the Company”), today announces it has completed the third cohort of its Phase 1 clinical trial…

Read More

“Get Ready to Celebrate: Tompkins Financial Corporation Announces Cash Dividend!”

newscaster02 mins

Breaking News: Tompkins Financial Corporation Announces Quarterly Dividend Payment What does this mean for shareholders? Today, Tompkins Financial Corporation (NYSE American:TMP) made an exciting announcement that its Board of Directors has approved the payment of a regular quarterly cash dividend of $0.62 per share. This dividend is payable on February 21, 2025, to common shareholders…

Read More